Artificial intelligence in diagnosis of mesothelioma

F. Galateau-Salle (Lyon, France)

Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care

Session: Diagnostic and therapeutic advances in mesothelioma care
Session type: Symposium
Number: 1238

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Galateau-Salle (Lyon, France). Artificial intelligence in diagnosis of mesothelioma. Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Artificial intelligence-mediated diagnosis of asbestosis Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021
Contemporary management of malignant mesothelioma Source: Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases Year: 2004
Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014
Diagnosis and staging of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Diagnosis of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Pathological diagnosis of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment Source: Eur Respir Rev 2016; 25: 472-486 Year: 2016
The reliability of the cytological diagnosis malignant mesothelioma Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002
Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013
Artificial intelligence meets interstitial lung diseases Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets? Year: 2019
Artificial intelligence in lung cancer: where are we now? Source: Virtual Congress 2020 – Imaging grand round Year: 2020
Treatment of malignant pleural mesothelioma: dilemmas Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005
Management of malignant mesothelioma Source: ERS Skills Course 2018 - Practical Pleural Skills Year: 2018
Artificial intelligence in pulmonary medicine Source: Virtual Congress 2021 – Scientific year in review Year: 2021
Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015
Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016